{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:42:13Z","timestamp":1774539733067,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Military Special Health Care Project","award":["Grant No. 15BJZ38"],"award-info":[{"award-number":["Grant No. 15BJZ38"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vascular Parkinsonism(VaP) is defined as parkinsonism resulting from cerebral vascular disease(CVD), with presence of variable motor and non-motor signs that are corroborated by clinical, anatomic or imaging findings of cerebrovascular disease. Overlapping syndromes with mixed pathologies make VaP difficult to distinguish from primary neurodegenerative parkinsonism.To understand the clinical and pathological features of VaP,we report a case of autopsy confirmed vascular Parkinsonism that was clinical misdiagnosed as idiopathic Parkinson\u2019s disease.Clinical features include early mixed symptoms of dementia,behavioral disturbance and parkinsonism that were similar to Dementia with lewy Body(DLB) and Parkinson disease Dementia(PDD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 84-year-old man presented progressive parkinsonism with prominent postural instability, gait impairment, pseudobulbar, early cognitive impairment, irritability, hallucination, urinary symptoms and poor responsiveness to dopaminergic drugs. He was clinically diagnosed as Parkinson disease(PD). In the post-mortem study, we examined A\u03b2 and phospho-tau as pathological biomarker for Alzheimer\u2019s disease(AD), \u03b1-synucleing in medulla, pons and midbrain for PD and DLB. Hematoxylin and eosin staining in cerebral cortex, cerebellum and brainstem examines vascular pathological changes and microvascular lesion.Neither Lewy bodies in the substantia nigra ,locus ceruleus and cerebrumnor accumulation of A\u03b2, neurofibrillary tangles were noted. Instead, there were many cerebral infarctions and widespread arteriosclerosis in the brain. The final brain autopsy supported a diagnosis of VaP not PD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case of pathologically confirmed VaP misdiagnosed as idiopathic PD suggested that we must be vigilant about the possibility of VaP for patients with parkinsonisms, cognitive impairments, early behavioral and psychological symptoms,imaging performances of cerebral small vessel disease and other vascular damages.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-020-02038-y","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T09:06:57Z","timestamp":1610356017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and Behavioral disturbance"],"prefix":"10.1186","volume":"21","author":[{"given":"Shouzi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"2038_CR1","doi-asserted-by":"crossref","unstructured":"Mehanna R. Joseph Jankovic. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013;12:597\u2013608.","DOI":"10.1016\/S1474-4422(13)70057-7"},{"key":"2038_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/ageing\/afi025","volume":"34","author":"B Thanvi","year":"2005","unstructured":"Thanvi B, Lo N, Robinson T. Vascular parkinsonism\u2014an important cause of parkinsonism in older people. Age Ageing. 2005;34:114\u201319.","journal-title":"Age Ageing"},{"key":"2038_CR3","doi-asserted-by":"crossref","unstructured":"Joaquin A, Vizcarra AE, Lang, Kapil D, Sethi, et al. Vascular Parkinsonnism: deconstructing a syndrome. Mov Disord 2015;30(7):886\u201394.","DOI":"10.1002\/mds.26263"},{"key":"2038_CR4","doi-asserted-by":"crossref","unstructured":"Bradley T, Hyman CH, Phelps,Thomas G. Beach,et al.National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.Alzheimers Dement. 2012; 8(1): 1\u201313.","DOI":"10.1016\/j.jalz.2011.10.007"},{"key":"2038_CR5","doi-asserted-by":"crossref","unstructured":"Thomas J, Montine,Creighton H,et al. National Institute on Aging\u2013Alzheimer\u2019s Association guidelines\u00a0for the neuropathologic assessment of Alzheimer\u2019s disease:a practical approach. Acta Neuropathol 2012;123:1\u201311.","DOI":"10.1007\/s00401-011-0910-3"},{"key":"2038_CR6","doi-asserted-by":"crossref","unstructured":"Handley A, Medcalf P, Hellier K, Dutta D. Movement disorders\u00a0after stroke. Age Ageing 2009;38:260\u201366.","DOI":"10.1093\/ageing\/afp020"},{"key":"2038_CR7","doi-asserted-by":"crossref","unstructured":"\u00a0Jellinger KA. Prevalence of cerebrovascular lesions in Parkinson\u2019s disease. A postmortem study.Acta Neuropathol. 2003;105:415\u20139.","DOI":"10.1007\/s00401-003-0676-3"},{"key":"2038_CR8","doi-asserted-by":"crossref","unstructured":"Van der Holst HM, van Uden IW, Tuladhar AM, et al.Cerebral small vessel disease and incident parkinsonism:The RUN DMC study. Neurology.2015;85:1569\u201377.","DOI":"10.1212\/WNL.0000000000002082"},{"key":"2038_CR9","doi-asserted-by":"crossref","unstructured":"\u00a0Glass PG, Lees AJ, Bacellar A, Zijlmans J, Katzenschlager R, Silveira-Moriyama L. The clinical features of pathologically confirmed vascular parkinsonism. J Neurol Neurosurg Psychiatry. 2012;83:1027\u20139.","DOI":"10.1136\/jnnp-2012-302828"},{"key":"2038_CR10","doi-asserted-by":"crossref","unstructured":"Yue Xing,Abdul Sapuan,Rob A Dineen,et al.Life span pigmentation changes of the subtantia nigra detected by neuromelanin-sensitive MRI.Mov Disord.2018;33(11):1792-99.","DOI":"10.1002\/mds.27502"},{"key":"2038_CR11","doi-asserted-by":"crossref","unstructured":"Ivan Rektor,Nicolaas I, Bohnen,et al. An Updated Diagnostic Approach to Subtype Definition of Vascular Parkinsonism Recommendations from an expert working group. Parkinsonism Relat Disord. 2018 April; 49: 9\u201316.","DOI":"10.1016\/j.parkreldis.2017.12.030"},{"key":"2038_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","volume":"11","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD. Vascular parkinsonism\u2013characteristics, pathogenesis and treatment. Nat Rev Neurol. 2015;11:319\u201326.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2038_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048607","volume":"21","author":"T Foltyniet","year":"2002","unstructured":"Foltyniet T, Barker R, Brayne C. Vascular parkinsonism:a review of the precision and frequency of the diagnosis. Neuroepidemiology. 2002;21(1):1\u20137.","journal-title":"Neuroepidemiology"},{"key":"2038_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483\u201397.","journal-title":"Lancet Neurol"},{"key":"2038_CR15","doi-asserted-by":"crossref","unstructured":"Ding J, Sigurosson S, Eiriksdottir JPV, Meirelles G, Kjartansson O. O, et al. Space and location of cerebral microbleeds,cognitive decline, and dementia in the community. Neurology. 2017;88:2089\u201397.","DOI":"10.1212\/WNL.0000000000003983"},{"key":"2038_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2017.02.018","volume":"54","author":"JR Romero","year":"2017","unstructured":"Romero JR, Beiser A, Himali JJ, Shoamanesh A, DeCarli C, Seshadri S. Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study. Neurobiol Aging. 2017;54:94\u20139.","journal-title":"Neurobiol Aging"},{"key":"2038_CR17","doi-asserted-by":"crossref","unstructured":"Sigurdsson S, Aspelund T, Kjartansson O, Gudmundsson. EF,Jonsdottir MK\u00a0Eiriksdottir G, et al. Incidence of brain infarcts,cognitive change, and risk of dementia in the general population:The AGES-Reykjavik Study (Age\u00a0Gene\/Environment SusceptibilityReykjavik. Study) Stroke. 2017;48:2353\u201360.","DOI":"10.1161\/STROKEAHA.117.017357"},{"key":"2038_CR18","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1161\/STROKEAHA.116.014695","volume":"47","author":"S Kaffashian","year":"2016","unstructured":"Kaffashian S, Soumare A, Zhu YC, Mazoyer B, Debette S. Tzourio C.Long-term clinical impact of vascular brain lesions on magnetic resonance imaging in older adults in the population. Stroke. 2016;47:2865\u20139.","journal-title":"Stroke"},{"key":"2038_CR19","doi-asserted-by":"crossref","unstructured":"Vizcarra JA, Lang AE, Sethi KD. Espay AJ.VascularParkinsonism:deconstructing a syndrome.Mov Disord. 2015; 30:886\u201394.","DOI":"10.1002\/mds.26263"},{"key":"2038_CR20","doi-asserted-by":"crossref","unstructured":"Ghebremedhin E, Rosenberger A, Rub. U,et al.Inverse relationship between\u00a0cerebrovascular lesions and severity. of lewy body pathology in patients with lewy body diseases. J Neuropathol Exp Neurol. 2010;69:442\u20138.","DOI":"10.1097\/NEN.0b013e3181d88e63"},{"key":"2038_CR21","doi-asserted-by":"crossref","unstructured":"Bohnen NI, Muller ML, Zarzhevsky N, et al. Leucoaraiosis, nigrostriatal denervation. and motor symptoms in Parkinson\u2019s disease. Brain. 2011;134:2358\u201365.","DOI":"10.1093\/brain\/awr139"},{"issue":"2","key":"2038_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.parkreldis.2013.10.025","volume":"20","author":"J Nacarro-Otano","year":"2014","unstructured":"Nacarro-Otano J, Gaig C, Muxi A, et al. 123I-MIBG cardiac uptake,smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascualar parkinsonism and Parkinson\u2019s disease [J]. Parkinsonism Relat Disord. 2014;20(2):192\u20137.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-02038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-02038-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-02038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T09:09:16Z","timestamp":1610356156000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-02038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-02038-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the patient\u2019s family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}